Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 2Phase NA 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Lymphoma 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Multiple Myeloma 8Leukemia, Myeloid, Acute 8Hodgkin Disease 8Recurrence 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Lymphocytic, Chronic, B-Cell 6Leukemia 6Burkitt Lymphoma 6Myelodysplastic Syndromes 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Neuroblastoma 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Dendritic Cell Sarcoma, Interdigitating 4Congenital Abnormalities 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Retinoblastoma 3Primary Myelofibrosis 3Myeloproliferative Disorders 3Mycosis Fungoides 3Lymphoma, Extranodal NK-T-Cell 3

Interventions

fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 1Melphalan 1Maintenance 1High-Throughput Screening Assays 1Dexamethasone 1Cyclosporine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Plasma Cell × Melphalan × Clear all
NCT04008888 2019-07-05

a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Unknown
50 enrolled
Other hematologic neoplasmPlasma cell

Chromosome 17 deletion, Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡